Ribociclib in newly diagnosed hepatitis B infection: A case report.

Fabrizio Di Costanzo,Simone Carrano,Gennaro Iengo,Amedeo Cefaliello,Valentina Cossiga,Filomena Morisco,Mario Giuliano,Carmine De Angelis,Grazia Arpino

Frontiers in oncology（2023）

引用 0|浏览19

暂无评分

摘要

hepatotoxicity of Ribociclib is reported as a possible side effect, and often positivity for hepatitis is cause of exclusion from therapy; in our case, no hepatotoxicity was noted and patient obtained response in terms of control of both infectious and oncological diseases.

查看译文

关键词

Ribociclib, hepatitis B, luminal breast cancer, CDK4, 6 inhibitors, tenofovir disoproxil fumarate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要